Cell-type-specific crosstalk between p38 MAPK and Rho signaling in lung micro- and macrovascular barrier dysfunction induced by Staphylococcus aureus-derived pathogens

Translational Research

Volumn 162, Issue 1, 2013, Pages 45-55

  Wu, Tinghuai ^a   Xing, Junjie ^a   Birukova, Anna A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOTEICHOIC ACID; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDOGLYCAN; RHO FACTOR; RHO KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL TYPE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG MACROVASCULAR BARRIER DYSFUNCTION; LUNG MICROVASCULAR BARRIER DYSFUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PULMONARY VASCULAR DISEASE; STAPHYLOCOCCUS AUREUS;

EID: 84879404379     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.03.005     Document Type: Article

References (46)

1. A. Melamed, and F.J. Sorvilloa The burden of sepsis-associated mortality in the united states from 1999 to 2005: an analysis of multiple-cause-of-death data Crit Care 13 2009 R28
2. M.A. Matthay, G.A. Zimmerman, and C. Esmon Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group Am J Respir Crit Care Med 167 2003 1027 1035
3. R.W. Pinner, S.M. Teutsch, and L. Simonsen Trends in infectious diseases mortality in the United States JAMA 275 1996 189 193
4. A. Gacouin, N. Barbarot, and C. Camus Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients Anesth Analg 109 2009 1584 1590
5. J. Hortal, M. Giannella, and M.J. Perez Incidence and risk factors for ventilator-associated pneumonia after major heart surgery Intensive Care Med 35 2009 1518 1525
6. A.J. Lechner, J.S. Ryerse, and G.M. Matuschak Acute lung injury during bacterial or fungal sepsis Microsc Res Tech 26 1993 444 456
7. A. Hayashida, A.H. Bartlett, and T.J. Foster Staphylococcus aureus beta-toxin induces lung injury through syndecan-1 Am J Pathol 174 2009 509 518
8. J.E. Wang, M.K. Dahle, and M. McDonald Peptidoglycan and lipoteichoic acid in Gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism Shock 20 2003 402 414
9. T. Kielian, A. Haney, and P.M. Mayes Toll-like receptor 2 modulates the proinflammatory milieu in Staphylococcus aureus-induced brain abscess Infect Immun 73 2005 7428 7435
10. J.C. Leemans, M.J. Vervoordeldonk, and S. Florquin Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Staphylococcus aureus Am J Respir Crit Care Med 165 2002 1445 1450
11. S.J. De Kimpe, M. Kengatharan, and C. Thiemermann The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure Proc Natl Acad Sci U S A 92 1995 10359 10363
12. M.G. Netea, C. van der Graaf, and J.W. Van der Meer Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system J Leukoc Biol 75 2004 749 755
13. K. Takeda, and S. Akira TLR signaling pathways Semin Immunol 16 2004 3 9
14. A.K. Mayer, M. Muehmer, and J. Mages Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells J Immunol 178 2007 3134 3142
15. J. Xing, N. Moldobaeva, and A.A. Birukova Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction J Appl Physiol 110 2011 213 224
16. L. Arbibe, J.P. Mira, and N. Teusch Toll-like receptor 2-mediated NF-kappa B activation requires a RAC1-dependent pathway Nat Immunol 1 2000 533 540
17. S.M. Dauphinee, and A. Karsan Lipopolysaccharide signaling in endothelial cells Lab Invest 86 2006 9 22
18. A.A. Birukova, K.G. Birukov, and B. Gorshkov Map kinases in lung endothelial permeability induced by microtubule disassembly Am J Physiol Lung Cell Mol Physiol 289 2005 L75 L84
19. A.K. Kiemer, N.C. Weber, and R. Furst Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability Circ Res 90 2002 874 881
20. F.E. Nwariaku, J. Chang, and X. Zhu The role of p38 MAP kinase in tumor necrosis factor-induced redistribution of vascular endothelial cadherin and increased endothelial permeability Shock 18 2002 82 85
21. M. Ruse, and U.G. Knaus New players in TLR-mediated innate immunity: Pi3k and small Rho GTPases Immunol Res 34 2006 33 48
22. A.A. Birukova, J. Xing, and P. Fu Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1 Am J Physiol Lung Cell Mol Physiol 299 2010 L652 L663
23. J. Xing, and A.A. Birukova ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha Microvasc Res 79 2010 26 62
24. N. Teusch, E. Lombardo, and J. Eddleston The low molecular weight GTPase RhoA and atypical protein kinase CZETA are required for TLR2-mediated gene transcription J Immunol 173 2004 507 514
25. F. He, J. Peng, and X.L. Deng RhoA and NF-kappaB are involved in lipopolysaccharide-induced brain microvascular cell line hyperpermeability Neuroscience 188 2011 35 47
26. M. Manukyan, P. Nalbant, and S. Luxen RhoA GTPase activation by TLR2 and TLR3 ligands: connecting via SRC to NF-kappa B J Immunol 182 2009 3522 3529
27. B. Schmeck, M. Brunsch, and J. Seybold Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells Inflammation 27 2003 89 95
28. V. Vouret-Craviari, P. Boquet, and J. Pouyssegur Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function Mol Biol Cell 9 1998 2639 2653
29. G.P. van Nieuw Amerongen, S. van Delft, and M.A. Vermeer Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases Circ Res 87 2000 335 340
30. Y. Fukata, M. Amano, and K. Kaibuchi Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells Trends Pharmacol Sci 22 2001 32 39
31. A.C. Hocke, B. Temmesfeld-Wollbrueck, and B. Schmeck Perturbation of endothelial junction proteins by Staphylococcus aureus alpha-toxin: inhibition of endothelial gap formation by adrenomedullin Histochem Cell Biol 126 2006 305 316
32. S. Tasaka, H. Koh, and W. Yamada Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632 Am J Respir Cell Mol Biol 32 2005 504 510
33. J.E. Slotta, O.O. Braun, and M.D. Menger Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo Inflamm Res 55 2006 364 367
34. K.G. Birukov, V.N. Bochkov, and A.A. Birukova Epoxycyclopentenone- containing oxidized phospholipids restore endothelial barrier function via CDC42 and RAC Circ Res 95 2004 892 901
35. A.A. Birukova, I. Cokic, and N. Moldobaeva Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF Am J Respir Cell Mol Biol 40 2009 99 107
36. A.A. Birukova, S. Chatchavalvanich, and A. Rios Differential regulation of pulmonary endothelial monolayer integrity by varying degrees of cyclic stretch Am J Pathol 168 2006 1749 1761
37. A.A. Birukova, N. Moldobaeva, and J. Xing Magnitude-dependent effects of cyclic stretch on HGF- and VEGF-induced pulmonary endothelial remodeling and barrier regulation Am J Physiol Lung Cell Mol Physiol 295 2008 L612 L623
38. A.A. Birukova, K. Smurova, and K.G. Birukov Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction Microvasc Res 67 2004 64 77
39. A.A. Birukova, Y. Tian, and A.Y. Meliton Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6 Am J Physiol Lung Cell Mol Physiol 302 2012 L965 L975
40. S. Liu, G. Feng, and G.L. Wang P38 MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway Eur J Pharmacol 584 2008 159 165
41. A.A. Birukova, P. Fu, and S. Chatchavalvanich Polar head groups are important for barrier protective effects of oxidized phospholipids on pulmonary endothelium Am J Physiol Lung Cell Mol Physiol 292 2007 L924 L935
42. P. Fu, A.A. Birukova, and J. Xing Amifostine reduces lung vascular permeability via suppression of inflammatory signalling Eur Respir J 33 2009 612 624
43. K. Lowe, D. Alvarez, and J. King Phenotypic heterogeneity in lung capillary and extra-alveolar endothelial cells: increased extra-alveolar endothelial permeability is sufficient to decrease compliance J Surg Res 143 2007 70 77
44. D.L. Cioffi, K. Lowe, and D.F. Alvarez TRPing on the lung endothelium: calcium channels that regulate barrier function Antioxid Redox Signal 11 2009 765 776
45. Q. Huang, J. Yang, and Y. Lin Differential regulation of interleukin 1 receptor and toll-like receptor signaling by MEKK3 Nat Immunol 5 2004 98 103
46. O. Shibolet, C. Giallourakis, and I. Rosenberg AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling J Biol Chem 282 2007 35308 35317